首页> 外文OA文献 >A Randomized Phase II Study of Gemcitabine and Carboplatin with or without Cediranib as First-Line Therapy in Advanced Non–Small-Cell Lung Cancer: North Central Cancer Treatment Group Study N0528

【2h】

A Randomized Phase II Study of Gemcitabine and Carboplatin with or without Cediranib as First-Line Therapy in Advanced Non–Small-Cell Lung Cancer: North Central Cancer Treatment Group Study N0528

机译：吉西他滨和卡铂联合或不联合西地尼布作为晚期非小细胞肺癌的一线治疗的随机II期研究：北部中部癌症治疗组研究N0528

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Dy Grace K.; Mandrekar Sumithra J.; Nelson Garth D.; Meyers Jeffrey P.; Adjei Araba A.; Ross Helen J.; Ansari Rafat H.; Lyss Alan P.; Stella Philip J.; Schild Steven E.; Molina Julian R.; Adjei Alex A.;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 来自一项艾日布林联合吉西他滨对比紫杉醇联合吉西他滨作为HER2阴性转移性乳腺癌的一线化疗的II期、多中心、随机试验的包含神经病变相关量表的生活质量结果:韩国癌症研究组试验(KCSG BR13-11) [J] . Ji-Yeon Kim, Young-Hyuck Im, Tae-Yong Kim, 癌症（英文版） . 2019,第008期
2. A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North central cancer treatment group study N0528 [J] . Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2013,第1期

机译：吉西他滨和卡铂联合或不联合西地尼布作为晚期非小细胞肺癌一线治疗的随机II期研究：北中部癌症治疗组研究N0528
3. Randomized phase II study of gemcitabine plus cisplatin, with or without cetuximab, as first-line therapy for patients with advanced or metastatic non small-cell lung cancer. [J] . Butts CA, Bodkin D, Middleman EL, Journal of Clinical Oncology . 2007,第36期

机译：吉西他滨联合顺铂（有或没有西妥昔单抗）作为晚期或转移性非小细胞肺癌患者的一线治疗的随机II期研究。
4. Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer. [J] . Gronberg BH, Bremnes RM, Flotten O Journal of Clinical Oncology . 2009,第19期

机译：挪威肺癌研究小组进行的III期研究：培美曲塞加卡铂与吉西他滨加卡铂作为晚期非小细胞肺癌的一线化疗药物。
5. Brain cortical structural differences between non-central nervous system cancer patients treated with and without chemotherapy compared to non-cancer controls: a cross-sectional pilot MRI study using clinically-indicated scans [C] . Mark S. Shiroishi, Vikash Gupta, Bavrina Bigjahan, 13th international conference on medical information processing and analysis . 2017

机译：与非癌症对照组相比，接受和不接受化疗的非中枢神经系统癌症患者的大脑皮层结构差异：采用临床指征扫描的横断面MRI研究
6. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
7. A Randomized Phase II Study of Gemcitabine and Carboplatin With or Without Cediranib as First-Line Therapy in Advanced Non-Small Cell Lung Cancer: North Central Cancer Treatment Group Study N0528 [O] . Grace K. Dy, Sumithra J. Mandrekar, Garth D. Nelson, -1

机译：吉西他滨的随机II期研究和卡铂带或不带西地尼布作为一线治疗晚期非小细胞肺癌：北部中心癌症治疗组研究N0528
8. Phase II Randomized Study of Vandetanib Plus Gemcitabine or Gemcitabine Plus Placebo as First-Line Treatment of Advanced Non–Small-Cell Lung Cancer in Elderly Patients [O] . Gridelli Cesare, Novello Silvia, Zilembo Nicoletta, 2014

机译：Vandetanib加吉西他滨或吉西他滨加安慰剂作为老年晚期非小细胞肺癌一线治疗的II期随机研究

A Randomized Phase II Study of Gemcitabine and Carboplatin with or without Cediranib as First-Line Therapy in Advanced Non–Small-Cell Lung Cancer: North Central Cancer Treatment Group Study N0528

著录项

引文网络

相似文献

相关主题

期刊订阅